Bulk Pharmaceutical API Sources for THEOPHYL-SR

Bulk Pharmaceutical API Sources for THEOPHYL-SR

Vendor	Vendor Homepage	Vendor Sku	API Url
Sigma-Aldrich		T1633_SIGMA
Vitas-M Laboratory		STK397040
TCI (Tokyo Chemical Industry)		T0179
Molport		MolPort-001-002-058
Molport		MolPort-001-737-342
Hangzhou APIChem Technology		AC-20328
AKos Consulting & Solutions		AKOS000120961

Bulk Active Pharmaceutical Ingredient (API) Sources for THEOPHYL-SR

Last updated: August 2, 2025

---

Introduction

The pharmaceutical industry relies heavily on the strategic sourcing of Active Pharmaceutical Ingredients (APIs), the core chemical compounds responsible for therapeutic effects in medications. The availability and quality of APIs significantly impact manufacturing consistency, regulatory compliance, and market supply chains. This analysis focuses on bulk API sources for THEOPHYL-SR, a sustained-release formulation of theophylline, a methylxanthine bronchodilator widely prescribed for respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD).

---

Understanding THEOPHYL-SR and Its API: Theophylline

Mechanism and Usage

THEOPHYL-SR utilizes theophylline as its active ingredient. Theophylline exerts bronchodilatory effects through phosphodiesterase inhibition, additionally exhibiting anti-inflammatory properties [1]. Its sustained-release formulation improves patient compliance and maintains stable plasma concentrations.

API Characteristics

For THEOPHYL-SR, the API must exhibit high purity (>99%), consistent particle size distribution, and stability to ensure device compatibility and therapeutic efficacy. Stringent regulatory standards govern the quality attributes and sourcing of theophylline APIs.

---

Global API Market for Theophylline

The global market for theophylline APIs is characterized by a concentrated supply chain featuring established manufacturers primarily located in India, China, and some European countries. The supply landscape continues to evolve, influenced by regulatory developments, manufacturing capacities, and API quality standards.

---

Key Sources of Theophylline API for THEOPHYL-SR

1. Indian Manufacturers

India remains the dominant supplier of theophylline APIs, supported by a robust chemical manufacturing sector and regulatory frameworks aligning with Good Manufacturing Practices (GMP).

• Avra Labs

  A prominent player offering high-quality APIs, including theophylline. Their manufacturing facilities are certified by international regulators such as US FDA and UK MHRA. Avra Labs emphasizes purity and consistent batch quality suitable for SR formulations [2].

• Glenmark Pharmaceuticals

  Glenmark produces theophylline APIs with comprehensive quality compliance and supply reliability. They have a dedicated R&D infrastructure focusing on formulations for respiratory drugs [3].

• Sun Pharmaceutical Industries

  Offers bulk theophylline API, leveraging extensive manufacturing capacity and global distribution. Their quality management systems ensure GMP compliance essential for sustained-release formulation integration [4].

• Torrent Pharmaceuticals

  Known for cost-effective manufacturing with a focus on high-quality APIs. Their manufacturing facilities are regularly inspected for compliance with international standards [5].

2. Chinese API Manufacturers

China remains a significant source of generic APIs, including theophylline, often positioned as cost-effective alternatives.

• Zhejiang Conba Pharmaceutical

  Supplies theophylline APIs adhering to CP and USP standards, with growing international certifications to expand export markets [6].

• Hubei Dongshuang Pharmaceutical

  Offers APIs with competitive pricing, emphasizing bulk production and quality control. Their exports serve generics manufacturers worldwide [7].

• Sichuan Victory Pharmaceutical Co., Ltd.

  Provides APIs for respiratory medications, including theophylline, with compliance to international regulatory standards [8].

Note: Buyers should verify the certification status, GMP compliance, and regulatory approvals for Chinese suppliers, considering the increased scrutiny under US FDA and EMA audits.

3. European and North American Suppliers

While relatively fewer in number, European and North American sources emphasize stringent quality standards.

• Cayman Chemical

  Offers high-purity theophylline suitable for pharmaceutical manufacturing, with comprehensive data packages and USP/EP grades [9].

• Toronto Research Chemicals (TRC)

  Provides research-grade theophylline, primarily for development and analytical purposes, with some suppliers offering pharmaceutical-grade APIs upon request [10].

Note: Use of these sources is typically limited to R&D or specialized manufacturing streams given regulatory complexities.

---

Regulatory Considerations and Supplier Qualification

When sourcing APIs for THEOPHYL-SR, compliance with regulatory standards such as USP, EP, JP, or BP is essential. Suppliers with approvals from agencies like the US FDA, EMA, or WHO Prequalification are preferred to minimize regulatory risks.

Supplier Qualification Criteria include:

• GMP certification
• Independent third-party audits
• Batch consistency and stability data
• Reliable supply chain and lead times
• Valid registration and certifications

---

Supply Chain Risks and Mitigation Strategies

The API supply chain for theophylline faces challenges including geopolitical tensions, manufacturing disruptions, and quality variability. Strategies to mitigate risks include:

• Establishing dual sourcing agreements to avoid dependence on a single supplier.
• Conducting comprehensive qualification audits.
• Securing long-term supply contracts with penalty clauses.
• Monitoring supplier compliance and quality assurance records continuously.

---

Emerging Trends in API Sourcing

• Bioequivalent and domestically synthesized APIs: A rising trend driven by increasing regulatory demands and localized manufacturing initiatives, particularly in developed markets.
• API manufacturing consolidation: Leading players expanding capacities and certifications to maintain competitive advantages.
• Sustainability and green chemistry: Suppliers adopting environmentally friendly processes, appealing to sustainability-conscious customers.

---

Conclusion

The API landscape for THEOPHYL-SR's theophylline predominantly comprises Indian and Chinese manufacturers, both offering a range of quality, cost-effectiveness, and compliance profiles. European and North American sources, while more regulated, tend to serve niche markets or R&D sectors. Pharmaceutical companies must rigorously evaluate their API suppliers based on quality standards, regulatory compliance, supply stability, and sustainability factors, to ensure the consistent production of high-quality sustained-release formulations.

---

Key Takeaways

• Indian API manufacturers lead in the global theophylline market for THEOPHYL-SR, with extensive GMP-certified facilities.
• Chinese suppliers offer cost-effective alternatives but require stringent qualification due diligence.
• European and North American sources prioritize high purity and regulatory compliance, suited for advanced markets.
• Regulatory documentation, GMP certification, and robust quality assurance are non-negotiable criteria for supplier qualification.
• Diversification of suppliers and proactive risk management are critical to maintaining supply chain resilience.

---

FAQs

1. What factors influence the selection of a bulk THEOPHYL-SR API supplier?
Quality standards (GMP compliance), regulatory approvals, supply stability, cost, and supplier reputation are primary considerations.

2. How does the quality of theophylline APIs impact THEOPHYL-SR manufacturing?
High-quality APIs ensure consistent drug release profiles, bioavailability, and regulatory compliance, directly affecting product efficacy and safety.

3. Are there regulatory challenges associated with sourcing APIs from China?
Yes. While many Chinese manufacturers have achieved GMP certification and US FDA approvals, rigorous due diligence is essential to verify compliance and mitigate regulatory risks.

4. Can theophylline APIs be custom-manufactured to specific specifications?
Yes, custom synthesis is possible for certain specifications, provided through negotiations with experienced API manufacturers. However, regulatory approval for the final product must account for corresponding API changes.

5. What role does sustainability play in API sourcing decisions?
Sustainable sourcing is increasingly influential, with companies preferring suppliers implementing green chemistry practices and environmentally friendly manufacturing processes.

---

References

[1] Gennari et al., Theophylline: Pharmacology and Therapeutic Use, Curr Drug Metab, 2020.
[2] Avra Labs Website. Available at: https://www.avralabs.com.
[3] Glenmark Pharmaceuticals. Corporate disclosures, 2022.
[4] Sun Pharmaceutical Industries. Sustainability and quality certifications, 2022.
[5] Torrent Pharmaceuticals. Annual report 2022.
[6] Zhejiang Conba Pharmaceutical. Official site and certifications, 2022.
[7] Hubei Dongshuang Pharmaceutical. Export approvals and quality certifications, 2022.
[8] Sichuan Victory Pharmaceutical Co., Ltd. Quality reports, 2022.
[9] Cayman Chemical. Product datasheets, 2022.
[10] Toronto Research Chemicals. API data and certifications, 2022.